+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Plastic, Type I Glass, Type II Glass), Capacity, Neck Finish - Global Forecast 2025-2030- Product Image
Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Plastic, Type I Glass, Type II Glass), Capacity, Neck Finish - Global Forecast 2025-2030- Product Image
Sale

Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Plastic, Type I Glass, Type II Glass), Capacity, Neck Finish - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146104
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in healthcare supply chains face new imperatives as the vaccine vials market pivots in response to global immunization demands, regulatory evolution, and technology-driven efficiency. Stakeholders must quickly assess emerging trends that influence strategic procurement, operational resilience, and sustainable growth.

Market Snapshot: Vaccine Vials Market Size, Growth, and Outlook

The vaccine vials market grew from USD 697.72 million in 2024 to USD 775.79 million in 2025. It is projected to continue expanding at a CAGR of 10.88%, culminating in USD 1.29 billion by 2030. These trends reflect heightened vaccine deployment and the industry’s quick adaptation to new supply and technology requirements.

Scope & Segmentation: Comprehensive Analysis of Vaccine Vials Market

  • Container Types: Single dose and multi-dose vials serve distinct immunization strategies and handling protocols.
  • Material Types: Multiple options—Type I, II, and III glass, cyclo olefin polymer, and polyethylene terephthalate—each bring advantages in cost, performance, and sustainability.
  • Container Sizes: Vials available in 2 mL, 5 mL, 10 mL, and 20 mL capacities, supporting a range of vaccination programs from specialized therapies to large-scale rollouts.
  • Neck Finishes: Crimp and screw closures allow for tailored compatibility with fill-finish lines and end-user preferences.
  • Regional Coverage: Americas—including United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina; EMEA—including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland; Asia-Pacific—including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Leading Companies: Key players include SCHOTT AG, Gerresheimer AG, Corning Incorporated, Stevanato Group S.p.A., SGD Pharma S.A., Nipro Corporation, Bormioli Pharma S.p.A., Ardagh Group S.A., Shandong Pharmaceutical Glass Co., Ltd., and Vitro, S.A.B. de C.V.
  • Technological Innovations: Integration of cyclo olefin polymers, high-speed automation, digital monitoring, and traceability features are reshaping vial design and production.

Key Takeaways for Senior Decision-Makers

  • Polymer alternatives are increasingly viable, challenging the established position of traditional glass and supporting sustainability goals.
  • Modern production lines feature modular automation, robotic systems, and enhanced traceability, targeting both efficiency and contamination risk reduction.
  • Dynamic market segmentation supports a variety of dosing regimens and logistics, improving adaptability for diverse immunization requirements.
  • Collaborations across the supply chain—including material science partnerships and turnkey service providers—accelerate regulatory readiness and product differentiation.
  • Regional infrastructure and fragmented regulations, particularly in Asia-Pacific and EMEA, influence site selection, market strategy, and investment priorities.
  • Leaders are exploring product customization and sustainability-focused digital solutions as competitive differentiators within the vaccine vials segment.

Tariff Impact: Navigating New U.S. Trade Dynamics

New United States tariffs on select raw materials and components have introduced increased input costs and lengthened equipment lead times for vaccine vial manufacturers. As a result, organizations are enhancing sourcing strategies by prioritizing nearshoring, engaging with domestic suppliers, and adopting alternative materials to improve cost stability and supply security. These shifts are prompting re-assessment of global manufacturing footprints and greater reliance on strategic supply partnerships.

Methodology & Data Sources

This analysis draws on direct interviews with executives, technical authorities, and procurement leaders throughout the fill-finish supply chain. Industry data from trade reports, regulatory documents, patent databases, and proprietary manufacturing dashboards informed scenario analysis and validation. Findings were reviewed by sector experts to ensure actionable relevance for decision-makers.

Why This Report Matters: Decision-Ready Insights for Leaders

  • Enables assessment of material and design innovations for operational efficiency, cost optimization, and long-term supply resilience.
  • Delivers regionally tuned intelligence on regulatory nuances, market-entry thresholds, and investment focus areas.
  • Informs strategic sourcing and partnership models to navigate tariff pressures and dynamic global trade environments.

Conclusion

The vaccine vials market is evolving through technological innovation, regulatory adaptation, and shifting regional supply priorities. Leaders poised to respond with agility, sustainability, and robust partnerships will shape future market outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of siliconized glass vials to enhance mRNA vaccine stability during extended cold chain distribution
5.2. Shift toward prefillable polymer vials with integrated RFID sensors for real-time cold chain monitoring
5.3. Growth in multi-dose vial utilization driven by cost efficiency and waste reduction in mass immunization campaigns
5.4. Expansion of contract manufacturing partnerships focusing on flexible low-volume specialty vaccine vial production
5.5. Development of lyophilized ready-to-use vaccine vial formats to minimize reliance on ultra-low temperature storage
5.6. Regulatory emphasis on harmonized vial closure systems to improve supply chain interoperability and safety
5.7. Innovation in antimicrobial vial coatings to reduce contamination risks in multi-dose vaccine administration
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaccine Vials Market, by Type
8.1. Introduction
8.2. Multi Dose
8.3. Single Dose
9. Vaccine Vials Market, by Material
9.1. Introduction
9.2. Plastic
9.2.1. Cyclo Olefin Polymer
9.2.2. Polyethylene Terephthalate
9.3. Type I Glass
9.4. Type II Glass
9.5. Type III Glass
10. Vaccine Vials Market, by Capacity
10.1. Introduction
10.2. 10 Ml
10.3. 2 Ml
10.4. 20 Ml
10.5. 5 Ml
11. Vaccine Vials Market, by Neck Finish
11.1. Introduction
11.2. Crimp
11.3. Screw
12. Americas Vaccine Vials Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vaccine Vials Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vaccine Vials Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. SCHOTT AG
15.3.2. Gerresheimer AG
15.3.3. Corning Incorporated
15.3.4. Stevanato Group S.p.A.
15.3.5. SGD Pharma S.A.
15.3.6. Nipro Corporation
15.3.7. Bormioli Pharma S.p.A.
15.3.8. Ardagh Group S.A.
15.3.9. Shandong Pharmaceutical Glass Co., Ltd.
15.3.10. Vitro, S.A.B. de C.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VACCINE VIALS MARKET: RESEARCHAI
FIGURE 24. VACCINE VIALS MARKET: RESEARCHSTATISTICS
FIGURE 25. VACCINE VIALS MARKET: RESEARCHCONTACTS
FIGURE 26. VACCINE VIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY CYCLO OLEFIN POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY CYCLO OLEFIN POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE I GLASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE I GLASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE II GLASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE II GLASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE III GLASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE III GLASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINE VIALS MARKET SIZE, BY 10 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VACCINE VIALS MARKET SIZE, BY 10 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINE VIALS MARKET SIZE, BY 2 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VACCINE VIALS MARKET SIZE, BY 2 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINE VIALS MARKET SIZE, BY 20 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VACCINE VIALS MARKET SIZE, BY 20 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINE VIALS MARKET SIZE, BY 5 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VACCINE VIALS MARKET SIZE, BY 5 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINE VIALS MARKET SIZE, BY CRIMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VACCINE VIALS MARKET SIZE, BY CRIMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINE VIALS MARKET SIZE, BY SCREW, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VACCINE VIALS MARKET SIZE, BY SCREW, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 71. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 74. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 75. CANADA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 76. CANADA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 77. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 78. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 79. CANADA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 80. CANADA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 81. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 84. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 85. MEXICO VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 86. MEXICO VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 87. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 88. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 89. MEXICO VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 90. MEXICO VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 133. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 136. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 137. GERMANY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 138. GERMANY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 139. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 140. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 141. GERMANY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 142. GERMANY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 143. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 146. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 147. FRANCE VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 148. FRANCE VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 149. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 150. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 151. FRANCE VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 152. FRANCE VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 163. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. ITALY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 168. ITALY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 169. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 170. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 171. ITALY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 172. ITALY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 173. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 176. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 177. SPAIN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 178. SPAIN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 179. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 180. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 181. SPAIN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 182. SPAIN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 213. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. DENMARK VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 218. DENMARK VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 219. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 220. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 221. DENMARK VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 222. DENMARK VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 233. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 236. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 237. QATAR VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 238. QATAR VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 239. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 240. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 241. QATAR VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 242. QATAR VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 243. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 246. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 247. FINLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 248. FINLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 249. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 250. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 251. FINLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 252. FINLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 273. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 276. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 277. EGYPT VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 278. EGYPT VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 279. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 280. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 281. EGYPT VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 282. EGYPT VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 283. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 284. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 285. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 286. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 287. TURKEY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 288. TURKEY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 289. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 290. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 291. TURKEY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 292. TURKEY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 303. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 304. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 305. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 306. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 307. NORWAY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 308. NORWAY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 309. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 310. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 311. NORWAY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 312. NORWAY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 313. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 316. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 317. POLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 318. POLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 319. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 320. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 321. POLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 322. POLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 334. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 345. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 346. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 347. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 348. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 349. CHINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 350. CHINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 351. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 352. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 353. CHINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 354. CHINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 355. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 356. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 357. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 358. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 359. INDIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 360. INDIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 361. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 362. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 363. INDIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 364. INDIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 365. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 366. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 367. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 368. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 369. JAPAN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 370. JAPAN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 371. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 372. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 373. JAPAN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 374. JAPAN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 375. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 376. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 377. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 378. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 379. AUSTRALIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
TABLE 380. AUSTRALIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2025-2030 (USD MILLION)
TABLE 381. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 382. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 383. AUSTRALIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2024 (USD MILLION)
TABLE 384. AUSTRALIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2025-2030 (USD MILLION)
TABLE 385. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 386. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 387. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 388. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vaccine Vials market report include:
  • SCHOTT AG
  • Gerresheimer AG
  • Corning Incorporated
  • Stevanato Group S.p.A.
  • SGD Pharma S.A.
  • Nipro Corporation
  • Bormioli Pharma S.p.A.
  • Ardagh Group S.A.
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Vitro, S.A.B. de C.V.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 775.79 Million
Forecasted Market Value ( USD ) by 2030 $ 1290 Million
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Depyrogenated Sterile Empty Vials Market by Product Type (Glass Vials, Plastic Vials), Application (Biotechnology, Diagnostics, Injectables), End User, Capacity, Sterilization Method - Global Forecast 2025-2030 - Product Image

Depyrogenated Sterile Empty Vials Market by Product Type (Glass Vials, Plastic Vials), Application (Biotechnology, Diagnostics, Injectables), End User, Capacity, Sterilization Method - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Vaccine Vials Market 2025-2033 - Product Image

Vaccine Vials Market 2025-2033

  • Report
  • 142 Pages
  • Global
From
Sterile Vials - Global Strategic Business Report - Product Image

Sterile Vials - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 154 Pages
  • Global
From
Vials Market - Forecasts from 2025 to 2030 - Product Image

Vials Market - Forecasts from 2025 to 2030

  • Report
  • 144 Pages
  • Global
From

About the Vaccine Vials Market

In the medical devices industry, the vaccine vials market comprises a segment dedicated to manufacturing the small glass or plastic containers used to hold and preserve vaccine doses. Vaccine vials are a critical component in the packaging and distribution of vaccines, ensuring the sterility, stability, and delivery of the immunizing agents they contain. Various types of vials exist, ranging from single-dose to multi-dose formats, with differing levels of protection against light and temperature changes. The market for vaccine vials is driven by the necessities of vaccine storage and safety, scalability for mass immunization efforts, and innovations in material sciences that contribute to the preservation of the vaccine's efficacy. The landscape of companies within the vaccine vials market includes names like Schott AG, Gerresheimer AG, and Nipro Corporation. These firms specialize in the production of pharmaceutical packaging, including glass and polymer vials. Becton, Dickinson and Company (BD) is another key player, known for its range of medical supplies and devices, including vaccine vials. Corning Incorporated has also made contributions to the market with their Valor Glass packaging solutions specifically designed for the storage and protection of vaccines. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.